Dr. Reddy's Laboratories (RDY) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Dr. Reddy's Laboratories Revenue Highlights


Latest Revenue (Y)

$279.16B

0

Main Geography (Y)

UNITED STATES

Dr. Reddy's Laboratories Revenue by Period


Dr. Reddy's Laboratories Revenue by Year

DateRevenueChange
2024-03-31$279.16B13.54%
2023-03-31$245.88B14.69%
2022-03-31$214.39B13.00%
2021-03-31$189.72B8.66%
2020-03-31$174.60B13.49%
2019-03-31$153.85B8.32%
2018-03-31$142.03B0.87%
2017-03-31$140.81B-8.98%
2016-03-31$154.71B4.40%
2015-03-31$148.19B12.12%
2014-03-31$132.17B13.68%
2013-03-31$116.27B20.19%
2012-03-31$96.74B29.51%
2011-03-31$74.69B6.28%
2010-03-31$70.28B1.20%
2009-03-31$69.44B38.87%
2008-03-31$50.01B-23.36%
2007-03-31$65.25B168.19%
2006-03-31$24.33B24.95%
2005-03-31$19.47B-3.24%
2004-03-31$20.12B11.69%
2003-03-31$18.02B8.51%
2002-03-31$16.60B51.85%
2001-03-31$10.94B-

Dr. Reddy's Laboratories generated $279.16B in revenue during NA 2024, up 13.54% compared to the previous quarter, and up 181.45% compared to the same period a year ago.

Dr. Reddy's Laboratories Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$72.15B4.86%
2023-09-30$68.80B2.10%
2023-06-30$67.38B7.01%
2023-03-31$62.97B-6.99%
2022-12-31$67.70B7.36%
2022-09-30$63.06B20.91%
2022-06-30$52.15B-4.07%
2022-03-31$54.37B2.20%
2021-12-31$53.20B-7.70%
2021-09-30$57.63B17.15%
2021-06-30$49.19B4.04%
2021-03-31$47.28B-4.08%
2020-12-31$49.30B0.67%
2020-09-30$48.97B10.85%
2020-06-30$44.17B-0.32%
2020-03-31$44.32B1.09%
2019-12-31$43.84B-8.69%
2019-09-30$48.01B24.91%
2019-06-30$38.44B-4.31%
2019-03-31$40.17B4.33%
2018-12-31$38.50B1.37%
2018-09-30$37.98B2.07%
2018-06-30$37.21B5.26%
2018-03-31$35.35B-7.12%
2017-12-31$38.06B7.33%
2017-09-30$35.46B6.94%
2017-06-30$33.16B-6.70%
2017-03-31$35.54B-4.11%
2016-12-31$37.06B3.37%
2016-09-30$35.86B10.86%
2016-06-30$32.34B-13.89%
2016-03-31$37.56B-5.34%
2015-12-31$39.68B-0.53%
2015-09-30$39.89B6.15%
2015-06-30$37.58B-2.91%
2015-03-31$38.70B0.71%
2014-12-31$38.43B7.11%
2014-09-30$35.88B2.00%
2014-06-30$35.17B1.05%
2014-03-31$34.81B-1.50%
2013-12-31$35.34B5.25%
2013-09-30$33.58B18.02%
2013-06-30$28.45B-14.82%
2013-03-31$33.40B16.58%
2012-12-31$28.65B-0.55%
2012-09-30$28.81B13.39%
2012-06-30$25.41B28.42%
2012-03-31$19.78B-28.56%
2011-12-31$27.69B22.11%
2011-09-30$22.68B14.63%
2011-06-30$19.78B-1.93%
2011-03-31$20.17B6.26%
2010-12-31$18.98B1.50%
2010-09-30$18.70B11.13%
2010-06-30$16.83B2.48%
2010-03-31$16.42B-5.05%
2009-12-31$17.30B-5.84%
2009-09-30$18.37B0.98%
2009-06-30$18.19B-8.37%
2009-03-31$19.85B7.88%
2008-12-31$18.40B13.93%
2008-09-30$16.15B7.40%
2008-06-30$15.04B13.76%
2008-03-31$13.22B-

Dr. Reddy's Laboratories generated - in revenue during Q4 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Dr. Reddy's Laboratories Revenue Breakdown


Dr. Reddy's Laboratories Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 24Mar 23Mar 22Mar 21Mar 20
Russia Country$22.30B$21.23B$20.88B$15.82B$16.90B
UNITED STATES$135.56B----
Others Countries Country$72.83B$67.47B$68.96B$60.95B$49.58B
India Country$48.47B$50.50B$43.99B$36.25B$32.09B

Dr. Reddy's Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (48.56%), Others Countries Country (26.09%), India Country (17.36%), and Russia Country (7.99%).

Dr. Reddy's Laboratories Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RDYDr. Reddy's Laboratories$279.16B-
ALKSAlkermes$1.66B$378.14M
PBHPrestige Consumer Healthcare$1.13B$267.14M
PAHCPhibro Animal Health$977.89M$263.22M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$178.02M
SUPNSupernus Pharmaceuticals$607.52M$168.32M
COLLCollegium Pharmaceutical$566.77M$144.92M
ANIPANI Pharmaceuticals$486.82M$138.04M
ITCIIntra-Cellular Therapies$462.18M$175.38M
EGRXEagle Pharmaceuticals$316.61M$64.65M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M
SSICSilver Spike Investment$11.72M$2.76B

RDY Revenue FAQ


Dr. Reddy's Laboratories's yearly revenue for 2024 was $279.16B, representing an increase of 13.54% compared to 2023. The company's yearly revenue for 2023 was $245.88B, representing an increase of 14.69% compared to 2022. RDY's yearly revenue for 2022 was $214.39B, representing an increase of 13.00% compared to 2021.

Dr. Reddy's Laboratories's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $72.15B, a 4.86% increase from the previous quarter (Q2 2024), and a 6.57% increase year-over-year (Q3 2023). RDY's quarterly revenue for Q2 2024 was $68.8B, a 2.10% increase from the previous quarter (Q1 2024), and a 9.11% increase year-over-year (Q2 2023).

Dr. Reddy's Laboratories's revenue growth rate for the last 3 years (2022-2024) was 30.21%, and for the last 5 years (2020-2024) was 59.89%.